Emergent respiratory infections – COVID-19 Flashcards

(28 cards)

1
Q

What is pneumonia and which parts of the lung does it affect?
A:

A

Pneumonia is the inflammation of the lung parenchyma located distal to the respiratory bronchioles.
It specifically involves the alveolar ducts, alveoli, and the interstitium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the common respiratory symptoms and how are they divided between the upper and lower respiratory tract?

A

▪ URT: nasal obstruction, nasal congestion, sneezing, epistaxis, cough, sore
throat, hoarseness, and stridor
▪ LRT: dyspnea, chest pain, cough, sputum, hemoptysis, and wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compare SARS-CoV, MERS-CoV, and SARS-CoV-2 in terms of outbreak date/location, receptor, and animal reservoir?

A

➔ SARS-CoV:
▪ Date and location: November 2002, Guangdong-China
▪ Binding receptor: ACE2 in the lower respiratory tract
▪ Animal reservoir: bats
➔ MERS-CoV:
▪ Date and location: June 2012, Jeddah-Saudi Arabia
▪ Binding receptor: DPP4 in the lower respiratory tract, GIT, and kidneys
▪ Animal reservoir: dromedaries
➔ SARS-CoV-2:
▪ Date and location: December 2019, Wuhan-China
▪ Binding receptor: ACE2 in the lower respiratory tract
▪ Animal reservoir: bats and pangolin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Compare SARS-CoV, MERS-CoV, and SARS-CoV-2 in terms of outbreak date/location, receptor, and animal reservoir?

A

➔ SARS-CoV:
▪ Date and location: November 2002, Guangdong-China
▪ Binding receptor: ACE2 in the lower respiratory tract
▪ Animal reservoir: bats
➔ MERS-CoV:
▪ Date and location: June 2012, Jeddah-Saudi Arabia
▪ Binding receptor: DPP4 in the lower respiratory tract, GIT, and kidneys
▪ Animal reservoir: dromedaries
➔ SARS-CoV-2:
▪ Date and location: December 2019, Wuhan-China
▪ Binding receptor: ACE2 in the lower respiratory tract
▪ Animal reservoir: bats and pangolin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the structure of the coronavirus, including its size, genome type, and components?

A

➔ Medium-sized virus size, but has the largest mRNA genome
➔ Enveloped positive sense single-stranded RNA

➔ Genome: mRNA encased in nucleocapsid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is the coronavirus named “corona” and what is the role of the spike proteins?

A

➔ Corona = Crowns for Spikes:
✓ Glycoprotein Spike (S) Peptomer
✓ Spikes: to attach to human cell receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What structural proteins are encoded by the coronavirus genome and what are their functions?

A
  • The genome encodes four or five structural proteins:
    ➔ S: spikes on the outside: mediates receptor binding
    ➔ M: membrane protein: assists viral assembly
    ➔ N: nucleocapsid protein: regulation of viral RNA synthesis, may interact with M
    protein during virus budding
    ➔ E: small envelope protein: function is not fully understood
    ➔ HE – hemagglutinin-esterase glycoprotein: enhances uptake into mucosal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does SARS-CoV-2 attach to human cells and where are ACE2 receptors highly expressed?

A

• SARS-CoV-2 attaches to human cells by binding to ACE2 receptors.

ACE2 receptors are highly expressed in:
1. Type 2 alveolar cells (highest concentration)
2. Bronchial epithelial cells
3. Tongue > buccal (cheek) epithelial cells

  • SARS-CoV-2 binds to ACE-2 Receptor 10-20x more strongly than SARS-CoV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the major COVID-19 variants and where were they first identified?

A
  • Alpha: UK
  • Beta: South Africa
  • Gamma: Brazil
  • Delta: India
  • Omicron: multiple countries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the most common symptoms experienced by people with COVID-19, and which one indicates pneumonia?

A

➔ Fever (83–99%)
➔ Cough (59–82%)

➔ Shortness of breath (31–40%) [serious and indicates pneumonia]

➔ Myalgia’s (11–35%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the incubation period of COVID-19 and how long does it usually last?

A

Pre-symptomatic incubation period extends from 2-14 days, may last a median of 5 days

  • During 1st week of illness, symptoms are flulike, with loss of taste and smell
  • Severe disease may develop in 2nd week, with dyspnea and the need for ICU treatment
  • Many patients remain asymptomatic during their illness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When is a person with COVID-19 most infectious, and how long does viral RNA remain detectable?

A

➔ Peaks between (two days before and one day after) symptom onset
➔ Declines within seven days

  • Median duration of viral RNA detection in specimens: 18 days following the onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main mode of SARS-CoV-2 transmission, and under what conditions does it occur?

A
  • Person-to-person spread is the main mode of SARS-CoV-2 transmission
  • Close-range contact (within two meters) via respiratory particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the classifications of COVID-19 severity and their key features?

A
  1. Mild (≈81%)
    • Symptoms of COVID-19
    • No viral pneumonia or hypoxia
    1. Moderate
      • Clinical signs of pneumonia
      • O₂ saturation ≥ 94%
    2. Severe (≈14%)
      • Severe pneumonia
      • O₂ saturation < 94%
      • Ground-glass opacities on imaging
    3. Critical (≈5%)
      • May include:
      🔸 Acute Respiratory Distress Syndrome (ARDS)
      🔸 Sepsis or Septic shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the case fatality rate of COVID-19, and what is its most common serious complication?

A

➔ The overall Case Fatality Rate (2.2%)
➔ Viral pneumonia is the most frequent serious clinical manifestation of COVID-19

which typically presents with:

hypoxemia, and bilateral opacities on CXR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the major risk factors for developing severe COVID-19 disease?

A

• Type 2 Diabetes Mellitus (DM)
• Chronic Kidney Disease (CKD)
• Obesity (BMI ≥ 30)
• Immunocompromised state, including:
• Solid organ transplant recipients
• Cancer
• Heart conditions:
• Heart Failure (HF)
• Coronary Artery Disease (CAD)
• Cardiomyopathy (CMP)
• Chronic Obstructive Pulmonary Disease (COPD)
• Pregnancy
• Smoking

17
Q

What is RT-PCR and what does it detect in COVID-19?
A1:

A

RT-PCR (Real-time Polymerase Chain Reaction) detects viral RNA of SARS-CoV-2.
It is 60–80% sensitive.

18
Q

What are the sample types used for RT-PCR testing in COVID-19?
A2:

A

• Nasal and oropharyngeal swabs (2 swabs – most common)
• Sputum (more accurate but riskier to collect)
• Stool (not generally used)
• Blood/Urine (virus not detected in these)

19
Q

When is RT-PCR most reliable in the course of infection?
A3:

A

RT-PCR is most reliable during the first 7 days of symptom onset.

20
Q

Does a negative RT-PCR rule out COVID-19?
A4:

A

No — a single negative RT-PCR does not exclude COVID-19.
If suspicion remains, repeat the test and consider isolation.

21
Q

What is the primary clinical use of the COVID-19 rapid antigen test?
A1:

A

It is used to diagnose current infection with SARS-CoV-2.

22
Q

How does the sensitivity of the rapid antigen test compare to PCR?
A3:
.

A

It is less sensitive than RT-PCR.
Its sensitivity is highest within 5–7 days of symptom onset in symptomatic patients

23
Q

What lab tests are commonly used to assess COVID-19 severity?

A

• D-dimer: Elevated → suggests hypercoagulability and risk of thrombosis.
• CRP: Elevated → indicates systemic inflammation.
• LDH: Elevated → reflects tissue (especially lung) damage.
• Troponin: Elevated → indicates myocardial injury.
• Ferritin: Elevated → marker of severe inflammation and possible cytokine storm.
• CPK: Elevated → suggests muscle or cardiac damage.
• Absolute lymphocyte count: Decreased → indicates lymphopenia, associated with worse prognosis.

24
Q

What laboratory abnormalities are commonly seen in hospitalized COVID-19 patients with coagulopathy?
A:

A

Hospitalized COVID-19 patients with coagulopathy may show:
• Mild thrombocytopenia (↓ platelets)
• ↑ D-dimer levels (marker of clot breakdown)
• ↑ Fibrin degradation products (FDPs)
• Prolonged prothrombin time (PT)

  • Elevated D-dimer levels are associated with greater risk of death
25
What thrombotic complications have been reported in hospitalized COVID-19 patients?
➔ DVT and PE – most frequent ➔ Microvascular thrombosis of the toes (“COVID toes”) - These patients should receive routine VTE prophylaxis with LMWH
26
Who should be screened for COVID-19 in the emergency room (ER)? A1:
Anyone presenting with flu-like illness or respiratory symptoms such as: • Fever • Cough • Shortness of breath
27
Who are the key groups that should be screened for COVID-19 besides symptomatic ER patients? A:
The following groups should also be screened for COVID-19: • Family members of newly diagnosed COVID-19 patients • Symptomatic healthcare workers • Travelers from certain (high-risk) countries • Patients undergoing procedures or surgical interventions
28
How do some of the main COVID-19 vaccines compare in terms of type, doses, effectiveness, storage, and cost? A:
• Oxford-AstraZeneca: Viral vector, 2 doses, 62–90% effective, fridge temp, £3 ($4) • Moderna: RNA, 2 doses, 95% effective, –20°C (6 months), £25 ($33) • Pfizer-BioNTech: RNA, 2 doses, 95% effective, –70°C, £15 ($20) • Sputnik V (Gamaleya): Viral vector, 2 doses, 92% effective, fridge temp (dry form), £7.5 ($10)